Study | Country | Year | Perspective | Discount rate (%) | Time horizon | Model structure |
---|---|---|---|---|---|---|
CUA of transplanting infectious kidneys (n = 03) | ||||||
 Kadatz et al. [26] | Canada | 2018 | Health- care payer and Societal | 1.5 | 10 years | Markov decision model |
 Kiberd et al. [27] | Canada | 1994 | Not explicitly stated (Health- care payer costs identified) | 5 | 20 years | Not explicitly stated (Markov decision model identified) |
 Schweitzer et al. [34] | USA | 2007 | Societal perspective | 3 | 20 years | Markov decision model |
CUA of kidney allocation policies (n = 09) | ||||||
 Axelrod et al. [21] | USA | 2018 | Health- care payer | 3 | 10 years | Discreet Event Simulation |
 Smith et al. [35] | USA | 2015 | Health- care payer | 3 | 20 years | Markov decision model |
 Mutinga et al. [31] | USA | 2005 | Not explicitly stated (Health- care payer costs identified) | 5 | 20 years | Markov decision model |
 Schnitzler et al. [33] | USA | 2003 | Health- care payer | 5 | 20 years | Markov decision model |
 Bavanandan et al. [23] | Malaysia | 2015 | Health- care payer | 3 | Life time | Not explicitly stated (Markov decision model identified) |
 Snyder et al. [36] | USA | 2010 | Societal perspective | 3 | 10 years | Markov decision model |
 Cavallo et al. [24] | Italy | 2014 | Health- care payer | 3.5 | 05 years | Markov decision model |
 Barnieh et al. [22] | Canada | 2013 | Health- care payer | 5 | Life time | Markov decision model |
 Matas et al. [29] | USA | 2003 | Societal perspective | 5 | 20 years | Markov decision model |
CUA of technology used in KT (n = 04) | ||||||
 Nguyen et al. [32] | Australia | 2015 | Health- care payer | 5 | 20 years | Markov decision model |
 McLaughlin et al. [30] | Canada | 2006 | Health- care payer | 5 | 25 years | Markov decision model |
 Groen et al. [25] | Europe | 2012 | Health- care payer | 4 | 10 years | Markov decision model |
 Liem et al. [28] | Netherlands | 2003 | Societal perspective | 3 | Life time | Markov decision model |